Sector: MedicalNastech Pharmaceutical Company, Inc. (NASDAQ: NSTK)
Ranking History
Scan Date: | 11/24/2009 |
Sector: | Medical |
Funamental : | 293 |
Technical : | 178 |
Performance : | 298 |
Overall: | 298 |
Number of Stocks: | 308 |
Scan Date: | 11/17/2009 |
Sector: | Medical |
Funamental : | 292 |
Technical : | 136 |
Performance : | 298 |
Overall: | 285 |
Number of Stocks: | 307 |
Scan Date: | 11/10/2009 |
Sector: | Medical |
Funamental : | 287 |
Technical : | 92 |
Performance : | 300 |
Overall: | 272 |
Number of Stocks: | 306 |
Headlines
- STREET MOVES: Two Friedman Billings Analysts Leave Firm
Feb 08, 2008 10:47 AM | AIS, BRL, CGPI, DUSA, ENDP, FBR
- P&G Finds Major Pharmaceutical Success Elusive
Dec 14, 2007 10:07 AM | ALXN, CRIS, IMA, NSTK, PG
- Dollar Pressure
Nov 07, 2007 10:28 AM | AINV, AIXG, ANW, APKT, ATRO, AUDC
- Pre-Market - Thursday August 9th
Aug 09, 2007 12:04 PM | AA, AIRN, AOB, BBI, BSC, CELL
- NASDAQ Technical Picture - Bulls Regain Momentum
Aug 09, 2007 02:15 AM | AAP, ABBI, ABI, ACF, AIRN, AOB
- Nastech Initiates New Corporate Direction with Name Change to MDRNA, Inc. and Appointment of J. Michael French as Chief Executive Officer
Jun 10, 2008 04:16 PM | NSTK
- Nastech Announces Positive Intranasal Insulin Data at American Diabetes Association Meeting
Jun 09, 2008 08:02 AM | NSTK
- Nastech Announces First Quarter 2008 Financial Results - Jun 2 2008 12:29AM
May 08, 2008 04:01 PM | NSTK
- Nastech to Release First Quarter Financial Results and Host Webcast on Thursday, May 8, 2008 - Jun 2 2008 12:28AM
May 01, 2008 04:04 PM | NSTK
- Nastech Pharmaceutical Company Inc. Raises $7.93 Million in Registered Direct Offering
Apr 25, 2008 08:03 AM | NSTK
- Nastech to Manufacture Nascobal(R) Nasal Spray for QOL Medical
Oct 17, 2005 02:27 PM | NSTK
- First Pet Life Has Partnered With PetCo, Announces the OTC Report
Jun 24, 2005 01:31 PM | EMKR, NSTK, PLLL
Analyst Ratings
Sentiment Survey
|
|
|
|
|
|
|
|
|
|
|
Share Performance
|
Period
|
NSTK
|
Compare to S&P
|
| YTD |
-69.47 %
|
-0.01 %
|
| 4 Weeks |
-10.77 %
|
-8.34 %
|
| 12 Weeks |
-51.26 %
|
-52.88 %
|
|
Financial Ratios
Earnings Performance
|
EPS Growth in Last Quarter: -23.40 %
|
|
EPS Growth in Last Year: -23.40 %
|
|
Sales Growth in Last Quarter: -80.23 %
|
|
Sales Growth in Last Quarter: -74.70 %
|
|
